Development of Swiss Biotechnology Beyond the Biopharmaceutical Sector In memoriam Prof. Dr. Oreste Ghisalba (1946–2018)


  • Hans-Peter Meyer University of Applied Sciences and Arts Western Switzerland HES SO, Institute of Life Technologies, Route du Rawyl, CH-1950 Sion, Switzerland;, Email:
  • Oleg Werbitzky NC Health Sciences, 1, rue Charles-Clos Olsommer, CH-3968 Veyras



Bio-based, Fine chemicals, Industrial biotechnology, Swiss economy, White biotechnology


Although diverse, the potential business opportunities for biotechnology outside the biopharmaceutical market are very large. White biotechnology can offer sustainable operations and products, while investments tend to be lower than those in red biotechnology. But a number of bottlenecks and roadblocks in Switzerland must be removed to realise the full potential of white biotechnology. This was also the point of view of Oreste Ghisalba, who wanted to be part of a new initiative to facilitate the creation of additional business, new processes and new products. This initiative requires the identification and the use of synergies and a much better cooperation between academia and industry through targeted networking. Unfortunately, we must carry on with this task without Oreste, whom we will miss for his deep knowledge and friendship.




How to Cite

H.-P. Meyer, O. Werbitzky, Chimia 2020, 74, 345, DOI: 10.2533/chimia.2020.345.